![]() |
市場調查報告書
商品編碼
1963853
超強吸收性敷料市場-全球產業規模、佔有率、趨勢、機會和預測:按產品類型、應用、最終用戶、地區和競爭格局分類,2021-2031年Superabsorbent Dressings Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Application, By End User, By Region & Competition, 2021-2031F |
||||||
全球超吸收性敷料市場預計將從 2025 年的 2.2311 億美元成長到 2031 年的 2.9711 億美元,複合年成長率為 4.89%。
這些專業的創傷護理產品採用多層芯材設計,能夠有效吸收並保留體液,從而有效處理中度至重度滲出液,防止皮膚浸漬。推動這一市場成長的主要因素是全球範圍內需要有效液體管理以促進癒合的慢性疾病(例如壓瘡和靜脈性腿部潰瘍)發病率的不斷上升。此外,全球人口老化,以及由此導致的手術量增加和與老齡化相關的皮膚脆弱性,也增加了居家照護和臨床環境中對這類吸收性產品的需求。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 2.2311億美元 |
| 市場規模:2031年 | 2.9711億美元 |
| 複合年成長率:2026-2031年 | 4.89% |
| 成長最快的細分市場 | 慢性傷口 |
| 最大的市場 | 北美洲 |
根據國際糖尿病聯盟(IDF)的數據,到2024年,全球將有約5.89億成年人患有糖尿病。如此龐大的患者群體導致糖尿病足潰瘍的發生率不斷上升,並對先進的滲出液管理解決方案產生了持續的需求。然而,與傳統創傷護理材料相比,先進敷料的高成本是阻礙市場成長的主要障礙。這種價格差異往往限制了它們的普及,尤其是在醫療報銷預算有限的地區。
慢性傷口,尤其是靜脈性腿部潰瘍和糖尿病足潰瘍在全球日益普遍,是吸收性敷料領域發展的主要驅動力。這些複雜的傷口通常會產生大量滲出液,而標準敷料難以有效吸收,因此,吸收性聚合物在旨在預防浸漬、隔離細菌和維持最佳濕潤環境的臨床通訊協定中至關重要。領先製造商的財務表現也印證了這一日益成長的臨床需求。例如,根據康維德集團(Convatec Group Plc)於2024年3月發布的“2023會計年度報告”,該公司先進創傷護理部門的收入成長了12.0%,達到6.95億美元,凸顯了全球對有效潰瘍治療方法日益成長的需求。
同時,與老化相關的生理變化,例如細胞再生速度減慢和皮膚彈性下降,進一步增加了對先進創傷護理解決方案的需求。老年人尤其容易出現血管併發症和壓瘡,對醫療保健系統造成沉重負擔,因此,高吸收性、長效敷料的使用日益受到重視,以減少照護時間。根據人口與社會安全研究所於2024年9月發布的《2024年世界人口資料表》,目前65歲以上人口占全球總人口的10%,約8億。這一人口趨勢正在推動行業成長,科樂普公司於2024年11月發布的《2023/24年度報告》證實了這一點,該報告顯示其先進創傷護理業務板塊實現了10%的內部成長。
超強吸收性敷料的高昂價格是其廣泛市場推廣的主要障礙,尤其與更經濟的替代品(如普通棉布或紗布)相比更是如此。儘管臨床證據顯示這些先進產品在處理大量滲出液方面卓有成效,但其高昂的價格令面臨財政緊縮的醫療採購部門卻步。這種成本差異在醫療資金有限的地區尤其關鍵,導致決策者優先考慮預算控制而非採用高階創傷護理技術,也阻礙了以降低單位成本為首要目標的公共醫療系統對這些技術的推廣應用。
這種經濟障礙因柔軟性的報銷政策而進一步加劇,這些政策往往無法充分涵蓋先進傷口護理產品的成本。根據歐洲傷口管理協會 (EWMA) 2024 年的報告,歐洲部分地區的報銷方案僅涵蓋先進創傷護理總成本的 60% 至 90%,剩餘部分則由患者或醫療機構承擔。這種部分補償導致人們繼續依賴價格較低的傳統材料,直接阻礙了全球超吸收性敷料市場的成長和收入擴張。
吸收性敷料市場的一項關鍵發展趨勢是向矽膠邊緣和非侵入性黏合劑的轉變,這主要源自於臨床上減少醫用黏合劑相關皮膚損傷(MARSI)的需求。與傳統黏合劑不同,後者在移除時可能會造成損傷,尤其是在皮膚脆弱的患者中,而矽膠配方提供了一種溫和的固定方式,能夠牢固地粘附在乾燥的皮膚上,同時易於移除且不會損傷角質層。這項技術進步提高了患者的依從性,延長了敷料的佩戴時間,從而為醫療保健機構帶來了經濟效益。這項轉變的商業性成功體現在近期的財務報告中。 Paul Hartmann AG 於 2024 年 3 月發布的 2023 會計年度年度報告中顯示,創傷護理業務的有機銷售額成長了 5.6%,這顯然歸功於該公司矽膠基吸收性敷料的強勁表現。
同時,抗菌劑的加入正將這些產品從被動的液體吸收器轉變為主動治療設備,用於感染控制。在全球對抗生素抗藥性日益關注的背景下,製造商正在將PHMB(次氯酸鈉)、碘和銀等抗菌劑添加到超吸收性敷料芯中,以主動降低敷料內的微生物附著量(微生物數量)並抑制生物膜的形成。這一趨勢旨在解決慢性傷口的複雜性問題,因為簡單的滲出液管理不足以應對此類傷口,使這些混合敷料成為感染控制的關鍵工具。市場數據也支持對生物活性解決方案的需求。根據史密斯醫療(Smith & Nephew)於2024年2月發布的“2023年第四季度及全年財務業績”,該公司“先進傷口生物活性產品”組合在第四季度實現了12.5%的核心收入成長,凸顯了感染控制療法的快速普及。
The Global Superabsorbent Dressings Market is projected to expand from USD 223.11 Million in 2025 to USD 297.11 Million by 2031, registering a CAGR of 4.89%. These specialized wound care solutions feature a multi-layered core designed to effectively manage moderate to heavy exudate by sequestering fluid and preventing skin maceration. A primary factor fueling this market growth is the increasing global incidence of chronic conditions, such as pressure injuries and venous leg ulcers, which require efficient fluid management to facilitate healing. Additionally, the aging global population supports demand due to higher rates of surgical procedures and age-related skin fragility, necessitating these absorbent products in both home care and clinical environments.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 223.11 Million |
| Market Size 2031 | USD 297.11 Million |
| CAGR 2026-2031 | 4.89% |
| Fastest Growing Segment | Chronic Wounds |
| Largest Market | North America |
According to the International Diabetes Federation, approximately 589 million adults worldwide were living with diabetes in 2024. This substantial patient base leads to a higher prevalence of diabetic foot ulcers, creating a continuous need for advanced exudate management solutions. However, a significant barrier potentially hindering market growth is the elevated cost of these advanced dressings compared to traditional wound care materials. This price disparity often restricts their adoption, particularly in regions where healthcare reimbursement budgets are limited.
Market Driver
The increasing global prevalence of chronic wounds, specifically venous leg ulcers and diabetic foot ulcers, serves as a major driver for the superabsorbent dressings sector. Because these complex injuries frequently generate high volumes of exudate that standard dressings cannot sufficiently handle, superabsorbent polymers have become essential in clinical protocols to prevent periwound maceration, sequester bacteria, and maintain optimal moisture balance. This growing clinical necessity is underscored by the financial results of leading manufacturers; for instance, according to Convatec Group Plc in March 2024, their Advanced Wound Care division reported a 12.0% revenue increase to $695 million in their 'Annual Results 2023', highlighting the rising global demand for effective ulcer therapies.
Concurrently, the expanding geriatric population intensifies the need for sophisticated wound care solutions due to physiological changes associated with aging, such as slower cellular regeneration and reduced skin elasticity. Older adults are disproportionately prone to vascular complications and pressure injuries, creating a burden on healthcare systems that encourages the use of highly absorbent, extended-wear dressings to reduce nursing time. According to the Population Reference Bureau's '2024 World Population Data Sheet' from September 2024, individuals aged 65 and older now make up 10% of the global population, totaling roughly 800 million people. This demographic trend drives industry growth, as evidenced by Coloplast A/S, which reported a 10% organic growth rate in its Advanced Wound Care business area in their 'Annual Report 2023/24' released in November 2024.
Market Challenge
The elevated price of superabsorbent dressings poses a substantial obstacle to broad market adoption, especially when compared to economical alternatives such as standard cotton wool or gauze. Despite clinical evidence demonstrating the effectiveness of these advanced products in handling heavy exudate, their premium pricing causes hesitation among healthcare procurement departments facing strict fiscal limitations. This cost disparity becomes a critical factor in areas with finite healthcare funding, often leading decision-makers to favor immediate budget compliance over the implementation of premium wound care technologies, thereby stifling uptake in public health systems focused on reducing unit costs.
This economic barrier is exacerbated by inflexible reimbursement policies that frequently fail to fully offset the expense of advanced wound management products. According to the European Wound Management Association in 2024, reimbursement schemes in certain European regions covered only 60% to 90% of the total costs for advanced wound care, forcing patients or healthcare providers to cover the financial shortfall. Such partial coverage encourages the continued reliance on less expensive, traditional materials, which directly impedes the volume expansion and revenue growth of the global superabsorbent dressings market.
Market Trends
A significant evolution in the superabsorbent dressings market is the transition toward silicone-bordered and atraumatic adhesives, driven by the clinical need to mitigate medical adhesive-related skin injuries (MARSI). Unlike traditional adhesives that may cause trauma upon removal, particularly for patients with friable or fragile skin, silicone formulations offer gentle fixation that secures well to dry skin but releases easily without damaging the stratum corneum. This technological advancement enhances patient compliance and enables longer wear times, offering economic benefits to healthcare providers. The commercial success of this shift is reflected in recent financial reports; according to Paul Hartmann AG's 'Annual Report 2023' from March 2024, the Wound Care segment posted 5.6% organic sales growth, explicitly attributed to the strong performance of their silicone superabsorbent dressings.
Simultaneously, the incorporation of antimicrobial agents for infection control is evolving these products from passive fluid absorbers into active therapeutic devices. Amidst global concerns regarding antibiotic resistance, manufacturers are infusing superabsorbent cores with agents like PHMB, iodine, or silver to actively lower bioburden and inhibit biofilm formation within the dressing. This trend addresses the complexities of chronic wounds where simple exudate management is insufficient, positioning these hybrid dressings as crucial tools for infection control. Market data supports the demand for bioactive solutions; according to Smith+Nephew's 'Fourth Quarter and Full Year 2023 Results' from February 2024, their Advanced Wound Bioactives portfolio achieved an underlying revenue growth of 12.5% in the fourth quarter, underscoring the rapid adoption of infection-managing therapies.
Report Scope
In this report, the Global Superabsorbent Dressings Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Superabsorbent Dressings Market.
Global Superabsorbent Dressings Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: